Our studies indicated that the deregulation of E2F1, E2F2, E2F3, E2F5, E2F7 and E2F8 in colon cancer tissues might play a vital role in colon cancer oncogenesis, which could be promising diagnostic biomarkers for LUAD. This evidence concerns the gene E2F5 and malignant colon neoplasm.